MetLife Investment Management’s Sana Biotechnology SANA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$192K	Sell	66,551 -26,575	-29%	-$105K	﹤0.01%	2252
2025 Q4	$379K	Buy	93,126 +14,120	+18%	+$63.2K	﹤0.01%	1925
2025 Q3	$280K	Sell	79,006 -2,499	-3%	-$9.04K	﹤0.01%	2122
2025 Q2	$223K	Buy	81,505 +639	+0.8%	+$1.32K	﹤0.01%	2134
2025 Q1	$136K	Buy	80,866 +53,208	+192%	+$149K	﹤0.01%	2386
2024 Q4	$45.1K	Sell	27,658 -49,952	-64%	-$149K	﹤0.01%	2748
2024 Q3	$323K	Hold	77,610	–	–	﹤0.01%	2019
2024 Q2	$424K	Buy	77,610 +29,289	+61%	+$233K	﹤0.01%	1815
2024 Q1	$483K	Hold	48,321	–	–	﹤0.01%	1695
2023 Q4	$197K	Hold	48,321	–	–	﹤0.01%	2256
2023 Q3	$187K	Hold	48,321	–	–	﹤0.01%	2254
2023 Q2	$288K	Hold	48,321	–	–	﹤0.01%	2041
2023 Q1	$158K	Hold	48,321	–	–	﹤0.01%	2358
2022 Q4	$191K	Hold	48,321	–	–	﹤0.01%	2275
2022 Q3	$290K	Hold	48,321	–	–	﹤0.01%	2048
2022 Q2	$311K	Hold	48,321	–	–	﹤0.01%	1994
2022 Q1	$399K	Buy	48,321 +17,543	+57%	+$142K	﹤0.01%	1920
2021 Q4	$476K	Hold	30,778	–	–	﹤0.01%	1532
2021 Q3	$693K	Buy	30,778 +19,193	+166%	+$403K	0.01%	1337
2021 Q2	$228K	Buy	+11,585	New	+$263K	﹤0.01%	2082